Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports.

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US ...

Lyndra Therapeutics Inc ceases operations due to funding issues, despite strategic investment from Sun Pharma in 2023.

The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn an additional $0.7 with the CVR.

Sun Pharmaceutical Industries, Inc., based in New Jersey, has recalled 9,840 bottles of Morphine Sulfate extended-release ...

India's largest drugmaker by revenue Sun Pharmaceutical (SUN.NS), opens new tab is aiming to launch its experimental anti-obesity and type 2 diabetes drug in the next four to five years ...

Sun Pharma Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

The US Food and Drug Administration (USFDA) has said Sun Pharma and Zydus Pharmaceuticals are recalling products in the US ...

In New Jersey, new initiatives support investment and job growth in the artificial intelligence and film and digital media ...